A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

Clinical trial NCT07751991 · RECRUITING

Trial details

NCT number: NCT07751991
Sponsor: Charm Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

AML (Acute Myeloid Leukemia)

Start date: 2026-08-01
Primary completion: 2027-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.